close
In order to translate an in vitro cellular model into the correct clinical interpretation of assay read-outs, a fully functional and validated model is needed.
Ncardia iPSC-derived cardiomyocytes and neurons are used in the assessment of safety pharmacology at the pre-clinical stage as well as drug efficacy testing. You can find our cardiomyocytes available as cryopreserved cells, or ready-to-go for specific applications in a CardioPlate™.
hiPSC-derived cardiomyocytes with a fully functional, ventricular phenotype for use in drug discovery and development. They are acquired without genetic modifications, and cultured in a well-defined, serum-free culture medium that enhances their functionality and maturity.
End the struggle in analyzing electrophysiology data when assessing drug effects in human-induced pluripotent stem cell-derived (hiPSC) cardiomyocytes. Ncyte CardioPlate Maestro MEA 96 is a ready-to-use Maestro™ MEA 96-well plate containing hiPSC-differentiated cardiomyocytes and medium.
Pluricyte® Cardiomyocytes on a Maestro 96 well MEA plate for MEA assays
Ncardia offers custom manufacturing of iPSC-derived cell models for application in drug discovery and cell therapy. Contact us to discuss custom manufacturing of your required cell type.
